Selective LC–MS/MS determination of citalopram enantiomers and application to a pharmacokinetic evaluation of generic and reference formulations

Two methods using LC–MS/MS were validated to quantify citalopram (CTP) racemate [(R/S)‐CTP] and the enantiomers (R)‐CTP and (S)‐CTP in human plasma, respectively. Paroxetine hydrochloride was used as the internal standard, and samples were extracted by protein precipitation with acetonitrile. The no...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedical chromatography 2022-01, Vol.36 (1), p.e5237-n/a
Hauptverfasser: Sousa, Carlos Eduardo Miranda, Bedor, Noely Camila Tavares Cavalcanti, Sousa, Giovana Damasceno, Oliveira, Guilherme Henrique Onório, Leal, Leila Bastos, Bedor, Danilo Cesar Galindo, Castro, Whocely Victor, Santana, Davi Pereira
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 1
container_start_page e5237
container_title Biomedical chromatography
container_volume 36
creator Sousa, Carlos Eduardo Miranda
Bedor, Noely Camila Tavares Cavalcanti
Sousa, Giovana Damasceno
Oliveira, Guilherme Henrique Onório
Leal, Leila Bastos
Bedor, Danilo Cesar Galindo
Castro, Whocely Victor
Santana, Davi Pereira
description Two methods using LC–MS/MS were validated to quantify citalopram (CTP) racemate [(R/S)‐CTP] and the enantiomers (R)‐CTP and (S)‐CTP in human plasma, respectively. Paroxetine hydrochloride was used as the internal standard, and samples were extracted by protein precipitation with acetonitrile. The non‐enantioselective method was conducted using a C18 column, and the mobile phase consisted of water for solvent A and acetonitrile for solvent B, both with 0.1% formic acid. For the chiral method, an analytical column Lux Cellulose‐1 was used. Mobile phase A was composed of water with 0.025% of formic acid and 0.05% of diethylamine, and mobile phase B consisted of acetonitrile:2‐propanol (95:5, v/v). No significant matrix effects were observed at the retention times of analytes and internal standard. The mean recovery was 89%, and the assays were linear in the concentration range of 1–50 and 5–30 ng/mL for the non‐enantioselective and enantioselective methods, respectively. The intra‐ and inter‐day precisions of both methods were less than 12.30%, and the accuracies were less than 12.13%. The validated methods were successfully applied to a pharmacokinetic study in which 20‐mg CTP tablets were administered to healthy volunteers, and their plasma levels were monitored over time in a bioequivalence study. Highlights Simple and rapid LC–MS/MS method for the quantification of citalopram and its enantiomers in human plasma. Both methods were demonstrated to be selective, reliable, and sensitive. Both methods have sufficient sensitivity to quantify the steady state through concentrations already reported for citalopram and escitalopram. Validated method presented in this study can be suitably applied to pharmacokinetic studies involving citalopram and escitalopram. Bland–Altman analysis suggested that non‐enantioselective and enantioselective methods can be applied in pharmacokinetic studies.
doi_str_mv 10.1002/bmc.5237
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2568609174</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2568609174</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2827-1c8bac5b24df0d61f2139e5910244277fc8d2cc9b9507ebe1524b43ccd90824d3</originalsourceid><addsrcrecordid>eNp1kctu1EAQRVsoiAwBiS-IepmNk-r2s5cwCg9pRiwG1la7XE6a9MN024my4xvgD_kSPJkQVqxKKp17VKrL2BsB5wJAXnQOz0uZ18_YSoBSGTQgjtgKZKWyvKnVMXuZ0jcAUJWsX7DjvCgqVYFYsZ87soSTuSW-Wf_-8Wu7u9jueE8TRWe8nkzwPAwczaRtGKN2nLz2y9pRTFz7nutxtAYP5BS45uO1jk5juDGeJoOcbrWdn0xX5Cku23000kCRPBIfQnSzfYDSK_Z80DbR68d5wr6-v_yy_phtPn_4tH67yVA2ss4ENp3GspNFP0BfiUGKXFGpBMiikHU9YNNLRNWpEmrqSJSy6IocsVfQLKH8hJ0dvGMM32dKU-tMQrJWewpzamVZNRUoURf_UIwhpeXsdozG6XjfCmj3DbRLA-2-gQU9fbTOnaP-Cfz78gXIDsCdsXT_X1H7brt-EP4B4lqTCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2568609174</pqid></control><display><type>article</type><title>Selective LC–MS/MS determination of citalopram enantiomers and application to a pharmacokinetic evaluation of generic and reference formulations</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Sousa, Carlos Eduardo Miranda ; Bedor, Noely Camila Tavares Cavalcanti ; Sousa, Giovana Damasceno ; Oliveira, Guilherme Henrique Onório ; Leal, Leila Bastos ; Bedor, Danilo Cesar Galindo ; Castro, Whocely Victor ; Santana, Davi Pereira</creator><creatorcontrib>Sousa, Carlos Eduardo Miranda ; Bedor, Noely Camila Tavares Cavalcanti ; Sousa, Giovana Damasceno ; Oliveira, Guilherme Henrique Onório ; Leal, Leila Bastos ; Bedor, Danilo Cesar Galindo ; Castro, Whocely Victor ; Santana, Davi Pereira</creatorcontrib><description>Two methods using LC–MS/MS were validated to quantify citalopram (CTP) racemate [(R/S)‐CTP] and the enantiomers (R)‐CTP and (S)‐CTP in human plasma, respectively. Paroxetine hydrochloride was used as the internal standard, and samples were extracted by protein precipitation with acetonitrile. The non‐enantioselective method was conducted using a C18 column, and the mobile phase consisted of water for solvent A and acetonitrile for solvent B, both with 0.1% formic acid. For the chiral method, an analytical column Lux Cellulose‐1 was used. Mobile phase A was composed of water with 0.025% of formic acid and 0.05% of diethylamine, and mobile phase B consisted of acetonitrile:2‐propanol (95:5, v/v). No significant matrix effects were observed at the retention times of analytes and internal standard. The mean recovery was 89%, and the assays were linear in the concentration range of 1–50 and 5–30 ng/mL for the non‐enantioselective and enantioselective methods, respectively. The intra‐ and inter‐day precisions of both methods were less than 12.30%, and the accuracies were less than 12.13%. The validated methods were successfully applied to a pharmacokinetic study in which 20‐mg CTP tablets were administered to healthy volunteers, and their plasma levels were monitored over time in a bioequivalence study. Highlights Simple and rapid LC–MS/MS method for the quantification of citalopram and its enantiomers in human plasma. Both methods were demonstrated to be selective, reliable, and sensitive. Both methods have sufficient sensitivity to quantify the steady state through concentrations already reported for citalopram and escitalopram. Validated method presented in this study can be suitably applied to pharmacokinetic studies involving citalopram and escitalopram. Bland–Altman analysis suggested that non‐enantioselective and enantioselective methods can be applied in pharmacokinetic studies.</description><identifier>ISSN: 0269-3879</identifier><identifier>EISSN: 1099-0801</identifier><identifier>DOI: 10.1002/bmc.5237</identifier><identifier>PMID: 34469601</identifier><language>eng</language><publisher>England</publisher><subject>Adolescent ; Adult ; bioequivalence ; Chromatography, Liquid - methods ; citalopram ; Citalopram - blood ; Citalopram - chemistry ; Citalopram - pharmacokinetics ; Dosage Forms ; enantiomers ; escitalopram ; Humans ; LC–MS/MS ; Linear Models ; Male ; Middle Aged ; pharmacokinetic ; Reproducibility of Results ; Sensitivity and Specificity ; Stereoisomerism ; Tandem Mass Spectrometry - methods ; Young Adult</subject><ispartof>Biomedical chromatography, 2022-01, Vol.36 (1), p.e5237-n/a</ispartof><rights>2021 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2827-1c8bac5b24df0d61f2139e5910244277fc8d2cc9b9507ebe1524b43ccd90824d3</cites><orcidid>0000-0002-8354-1843 ; 0000-0002-3901-9126</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbmc.5237$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbmc.5237$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34469601$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sousa, Carlos Eduardo Miranda</creatorcontrib><creatorcontrib>Bedor, Noely Camila Tavares Cavalcanti</creatorcontrib><creatorcontrib>Sousa, Giovana Damasceno</creatorcontrib><creatorcontrib>Oliveira, Guilherme Henrique Onório</creatorcontrib><creatorcontrib>Leal, Leila Bastos</creatorcontrib><creatorcontrib>Bedor, Danilo Cesar Galindo</creatorcontrib><creatorcontrib>Castro, Whocely Victor</creatorcontrib><creatorcontrib>Santana, Davi Pereira</creatorcontrib><title>Selective LC–MS/MS determination of citalopram enantiomers and application to a pharmacokinetic evaluation of generic and reference formulations</title><title>Biomedical chromatography</title><addtitle>Biomed Chromatogr</addtitle><description>Two methods using LC–MS/MS were validated to quantify citalopram (CTP) racemate [(R/S)‐CTP] and the enantiomers (R)‐CTP and (S)‐CTP in human plasma, respectively. Paroxetine hydrochloride was used as the internal standard, and samples were extracted by protein precipitation with acetonitrile. The non‐enantioselective method was conducted using a C18 column, and the mobile phase consisted of water for solvent A and acetonitrile for solvent B, both with 0.1% formic acid. For the chiral method, an analytical column Lux Cellulose‐1 was used. Mobile phase A was composed of water with 0.025% of formic acid and 0.05% of diethylamine, and mobile phase B consisted of acetonitrile:2‐propanol (95:5, v/v). No significant matrix effects were observed at the retention times of analytes and internal standard. The mean recovery was 89%, and the assays were linear in the concentration range of 1–50 and 5–30 ng/mL for the non‐enantioselective and enantioselective methods, respectively. The intra‐ and inter‐day precisions of both methods were less than 12.30%, and the accuracies were less than 12.13%. The validated methods were successfully applied to a pharmacokinetic study in which 20‐mg CTP tablets were administered to healthy volunteers, and their plasma levels were monitored over time in a bioequivalence study. Highlights Simple and rapid LC–MS/MS method for the quantification of citalopram and its enantiomers in human plasma. Both methods were demonstrated to be selective, reliable, and sensitive. Both methods have sufficient sensitivity to quantify the steady state through concentrations already reported for citalopram and escitalopram. Validated method presented in this study can be suitably applied to pharmacokinetic studies involving citalopram and escitalopram. Bland–Altman analysis suggested that non‐enantioselective and enantioselective methods can be applied in pharmacokinetic studies.</description><subject>Adolescent</subject><subject>Adult</subject><subject>bioequivalence</subject><subject>Chromatography, Liquid - methods</subject><subject>citalopram</subject><subject>Citalopram - blood</subject><subject>Citalopram - chemistry</subject><subject>Citalopram - pharmacokinetics</subject><subject>Dosage Forms</subject><subject>enantiomers</subject><subject>escitalopram</subject><subject>Humans</subject><subject>LC–MS/MS</subject><subject>Linear Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>pharmacokinetic</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Stereoisomerism</subject><subject>Tandem Mass Spectrometry - methods</subject><subject>Young Adult</subject><issn>0269-3879</issn><issn>1099-0801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctu1EAQRVsoiAwBiS-IepmNk-r2s5cwCg9pRiwG1la7XE6a9MN024my4xvgD_kSPJkQVqxKKp17VKrL2BsB5wJAXnQOz0uZ18_YSoBSGTQgjtgKZKWyvKnVMXuZ0jcAUJWsX7DjvCgqVYFYsZ87soSTuSW-Wf_-8Wu7u9jueE8TRWe8nkzwPAwczaRtGKN2nLz2y9pRTFz7nutxtAYP5BS45uO1jk5juDGeJoOcbrWdn0xX5Cku23000kCRPBIfQnSzfYDSK_Z80DbR68d5wr6-v_yy_phtPn_4tH67yVA2ss4ENp3GspNFP0BfiUGKXFGpBMiikHU9YNNLRNWpEmrqSJSy6IocsVfQLKH8hJ0dvGMM32dKU-tMQrJWewpzamVZNRUoURf_UIwhpeXsdozG6XjfCmj3DbRLA-2-gQU9fbTOnaP-Cfz78gXIDsCdsXT_X1H7brt-EP4B4lqTCQ</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Sousa, Carlos Eduardo Miranda</creator><creator>Bedor, Noely Camila Tavares Cavalcanti</creator><creator>Sousa, Giovana Damasceno</creator><creator>Oliveira, Guilherme Henrique Onório</creator><creator>Leal, Leila Bastos</creator><creator>Bedor, Danilo Cesar Galindo</creator><creator>Castro, Whocely Victor</creator><creator>Santana, Davi Pereira</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8354-1843</orcidid><orcidid>https://orcid.org/0000-0002-3901-9126</orcidid></search><sort><creationdate>202201</creationdate><title>Selective LC–MS/MS determination of citalopram enantiomers and application to a pharmacokinetic evaluation of generic and reference formulations</title><author>Sousa, Carlos Eduardo Miranda ; Bedor, Noely Camila Tavares Cavalcanti ; Sousa, Giovana Damasceno ; Oliveira, Guilherme Henrique Onório ; Leal, Leila Bastos ; Bedor, Danilo Cesar Galindo ; Castro, Whocely Victor ; Santana, Davi Pereira</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2827-1c8bac5b24df0d61f2139e5910244277fc8d2cc9b9507ebe1524b43ccd90824d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>bioequivalence</topic><topic>Chromatography, Liquid - methods</topic><topic>citalopram</topic><topic>Citalopram - blood</topic><topic>Citalopram - chemistry</topic><topic>Citalopram - pharmacokinetics</topic><topic>Dosage Forms</topic><topic>enantiomers</topic><topic>escitalopram</topic><topic>Humans</topic><topic>LC–MS/MS</topic><topic>Linear Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>pharmacokinetic</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Stereoisomerism</topic><topic>Tandem Mass Spectrometry - methods</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sousa, Carlos Eduardo Miranda</creatorcontrib><creatorcontrib>Bedor, Noely Camila Tavares Cavalcanti</creatorcontrib><creatorcontrib>Sousa, Giovana Damasceno</creatorcontrib><creatorcontrib>Oliveira, Guilherme Henrique Onório</creatorcontrib><creatorcontrib>Leal, Leila Bastos</creatorcontrib><creatorcontrib>Bedor, Danilo Cesar Galindo</creatorcontrib><creatorcontrib>Castro, Whocely Victor</creatorcontrib><creatorcontrib>Santana, Davi Pereira</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedical chromatography</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sousa, Carlos Eduardo Miranda</au><au>Bedor, Noely Camila Tavares Cavalcanti</au><au>Sousa, Giovana Damasceno</au><au>Oliveira, Guilherme Henrique Onório</au><au>Leal, Leila Bastos</au><au>Bedor, Danilo Cesar Galindo</au><au>Castro, Whocely Victor</au><au>Santana, Davi Pereira</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective LC–MS/MS determination of citalopram enantiomers and application to a pharmacokinetic evaluation of generic and reference formulations</atitle><jtitle>Biomedical chromatography</jtitle><addtitle>Biomed Chromatogr</addtitle><date>2022-01</date><risdate>2022</risdate><volume>36</volume><issue>1</issue><spage>e5237</spage><epage>n/a</epage><pages>e5237-n/a</pages><issn>0269-3879</issn><eissn>1099-0801</eissn><abstract>Two methods using LC–MS/MS were validated to quantify citalopram (CTP) racemate [(R/S)‐CTP] and the enantiomers (R)‐CTP and (S)‐CTP in human plasma, respectively. Paroxetine hydrochloride was used as the internal standard, and samples were extracted by protein precipitation with acetonitrile. The non‐enantioselective method was conducted using a C18 column, and the mobile phase consisted of water for solvent A and acetonitrile for solvent B, both with 0.1% formic acid. For the chiral method, an analytical column Lux Cellulose‐1 was used. Mobile phase A was composed of water with 0.025% of formic acid and 0.05% of diethylamine, and mobile phase B consisted of acetonitrile:2‐propanol (95:5, v/v). No significant matrix effects were observed at the retention times of analytes and internal standard. The mean recovery was 89%, and the assays were linear in the concentration range of 1–50 and 5–30 ng/mL for the non‐enantioselective and enantioselective methods, respectively. The intra‐ and inter‐day precisions of both methods were less than 12.30%, and the accuracies were less than 12.13%. The validated methods were successfully applied to a pharmacokinetic study in which 20‐mg CTP tablets were administered to healthy volunteers, and their plasma levels were monitored over time in a bioequivalence study. Highlights Simple and rapid LC–MS/MS method for the quantification of citalopram and its enantiomers in human plasma. Both methods were demonstrated to be selective, reliable, and sensitive. Both methods have sufficient sensitivity to quantify the steady state through concentrations already reported for citalopram and escitalopram. Validated method presented in this study can be suitably applied to pharmacokinetic studies involving citalopram and escitalopram. Bland–Altman analysis suggested that non‐enantioselective and enantioselective methods can be applied in pharmacokinetic studies.</abstract><cop>England</cop><pmid>34469601</pmid><doi>10.1002/bmc.5237</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-8354-1843</orcidid><orcidid>https://orcid.org/0000-0002-3901-9126</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0269-3879
ispartof Biomedical chromatography, 2022-01, Vol.36 (1), p.e5237-n/a
issn 0269-3879
1099-0801
language eng
recordid cdi_proquest_miscellaneous_2568609174
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adolescent
Adult
bioequivalence
Chromatography, Liquid - methods
citalopram
Citalopram - blood
Citalopram - chemistry
Citalopram - pharmacokinetics
Dosage Forms
enantiomers
escitalopram
Humans
LC–MS/MS
Linear Models
Male
Middle Aged
pharmacokinetic
Reproducibility of Results
Sensitivity and Specificity
Stereoisomerism
Tandem Mass Spectrometry - methods
Young Adult
title Selective LC–MS/MS determination of citalopram enantiomers and application to a pharmacokinetic evaluation of generic and reference formulations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T13%3A27%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20LC%E2%80%93MS/MS%20determination%20of%20citalopram%20enantiomers%20and%20application%20to%20a%20pharmacokinetic%20evaluation%20of%20generic%20and%20reference%20formulations&rft.jtitle=Biomedical%20chromatography&rft.au=Sousa,%20Carlos%20Eduardo%20Miranda&rft.date=2022-01&rft.volume=36&rft.issue=1&rft.spage=e5237&rft.epage=n/a&rft.pages=e5237-n/a&rft.issn=0269-3879&rft.eissn=1099-0801&rft_id=info:doi/10.1002/bmc.5237&rft_dat=%3Cproquest_cross%3E2568609174%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2568609174&rft_id=info:pmid/34469601&rfr_iscdi=true